News Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Real-time Euronext Paris Other stock markets 10:23:57 2024-04-18 am EDT			5-day change	1st Jan Change
0.4 ^EUR	+1.52%		-2.32%	-15.07%

Apr. 03	Mauna Kea: first Italian center for Cellvizio	CF
Mar. 27	Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mauna Kea: first Italian center for Cellvizio	Apr. 03	CF
Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Apr. 02	BU
Mauna Kea Technologies : Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Apr. 02	PU
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	Mar. 27	BU
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	Mar. 27	CI
Mauna Kea: partnership with Metrodora Institute in the USA	Mar. 06	CF
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Mar. 06	BU
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	Mar. 06	CI
MAUNA KEA TECHNOLOGIES REPORTS FULL YEAR 2023 SALES OF EUR10.5M, UP +42% VS 2022	Jan. 26	AQ
Mauna Kea: Johnson & Johnson Innovation below 20% threshold	Nov. 24	CF
Mauna Kea Technologies to Receive EUR6 Million Investment from Telix Pharmaceuticals	Nov. 13	MT
Mauna Kea: share price surges as Telix acquires 19% stake	Nov. 13	CF
Telix Pharmaceuticals Limited and Mauna Kea Technologies SA to Expand Collaboration in Urologic Oncology Surgery	Nov. 13	CI
Mauna Kea Technologies SA announced that it expects to receive ?6 million in funding from Telix Pharmaceuticals Limited	Nov. 12	CI
Mauna Kea Technologies : Inside Information / Other news releases	Nov. 02	PU
Mauna Kea Technologies Announces First Patient Enrolled in the Pivotal CLEVER Clinical Trial in Peripheral Lung Cancer	Nov. 02	CI
Mauna Kea Technologies Reports Sales Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-19	CI
Mauna Kea Technologies Announces the Publication of Positive Results of a Randomized Controlled Trial in the Field of Interstitial Lung Disease	23-10-18	AQ
Mauna Kea Technologies SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Mauna Kea Technologies and Endoscopy Institute of Hawaii Achieve 1,200 Procedure Milestone	23-09-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mauna Kea Technologies

Equities

ALMKT

FR0010609263

Summary

Filters